175 related articles for article (PubMed ID: 19581762)
1. Pancreatic stellate cells and pancreatic carcinoma: an unholy alliance.
Löhr JM; Jesnowski R
JOP; 2009 Jul; 10(4):472-3. PubMed ID: 19581762
[No Abstract] [Full Text] [Related]
2. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
4. Preferential increase of extracellular matrix expression relative to transforming growth factor beta1 in the pancreas during the early stage of acute hemorrhagic pancreatitis in rats.
Nakamura H; Tashiro M; Yamaguchi T; Asaumi H; Nomiyama Y; Watanabe S; Nagashio Y; Miyamoto T; Otsuki M
Pancreas; 2007 Nov; 35(4):e23-9. PubMed ID: 18090228
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression.
Kitaura Y; Chikazawa N; Tasaka T; Nakano K; Tanaka M; Onishi H; Katano M
Pancreas; 2011 Oct; 40(7):1034-42. PubMed ID: 21697762
[TBL] [Abstract][Full Text] [Related]
6. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
[TBL] [Abstract][Full Text] [Related]
7. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression.
Dangi-Garimella S; Strouch MJ; Grippo PJ; Bentrem DJ; Munshi HG
Oncogene; 2011 Feb; 30(8):1002-8. PubMed ID: 21057545
[TBL] [Abstract][Full Text] [Related]
8. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
Berchtold S; Grünwald B; Krüger A; Reithmeier A; Hähl T; Cheng T; Feuchtinger A; Born D; Erkan M; Kleeff J; Esposito I
Cancer Lett; 2015 Jan; 356(2 Pt B):721-32. PubMed ID: 25449434
[TBL] [Abstract][Full Text] [Related]
9. Fibrogenesis in the pancreas.
Ellenrieder V; Schneiderhan W; Bachem M; Adler G
Rocz Akad Med Bialymst; 2004; 49():40-6. PubMed ID: 15631312
[TBL] [Abstract][Full Text] [Related]
10. The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells.
Zhang Q; Li J; Deavers M; Abbruzzese JL; Ho L
J Histochem Cytochem; 2005 Nov; 53(11):1371-82. PubMed ID: 15956034
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells.
Tien YW; Wu YM; Lin WC; Lee HS; Lee PH
J Hepatol; 2009 Aug; 51(2):307-14. PubMed ID: 19464749
[TBL] [Abstract][Full Text] [Related]
12. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Yamaguchi H; Shimizu M; Ban S; Koyama I; Hatori T; Fujita I; Yamamoto M; Kawamura S; Kobayashi M; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Ebihara Y; Koike N; Furukawa T
Am J Surg Pathol; 2009 Aug; 33(8):1164-72. PubMed ID: 19440145
[TBL] [Abstract][Full Text] [Related]
13. Ductal cells of the pancreas.
Grapin-Botton A
Int J Biochem Cell Biol; 2005 Mar; 37(3):504-10. PubMed ID: 15618005
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.
Bachem MG; Schünemann M; Ramadani M; Siech M; Beger H; Buck A; Zhou S; Schmid-Kotsas A; Adler G
Gastroenterology; 2005 Apr; 128(4):907-21. PubMed ID: 15825074
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer.
Bu XM; Zhao CH; Dai XW
Chin Med J (Engl); 2008 May; 121(10):952-5. PubMed ID: 18706212
[No Abstract] [Full Text] [Related]
16. Carcinoma of the exocrine pancreas: the histology report.
Capella C; Albarello L; Capelli P; Sessa F; Zamboni G; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S282-92. PubMed ID: 21459334
[TBL] [Abstract][Full Text] [Related]
17. A Case of Pancreatic Ductal Adenocarcinoma Arising From Atypical Flat Lesions.
Franklin O; Öman M; Wanders A
Pancreas; 2020 Aug; 49(7):e60-e61. PubMed ID: 32658071
[No Abstract] [Full Text] [Related]
18. Pancreatic Cancer and Osteopontin: The Relationship Remains Unclear.
Weber CE; Erşahin ÇH; Kuo PC; Mi Z
Pancreas; 2016 Aug; 45(7):e35-6. PubMed ID: 27400159
[No Abstract] [Full Text] [Related]
19. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
Armstrong T; Packham G; Murphy LB; Bateman AC; Conti JA; Fine DR; Johnson CD; Benyon RC; Iredale JP
Clin Cancer Res; 2004 Nov; 10(21):7427-37. PubMed ID: 15534120
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance.
Vonlaufen A; Phillips PA; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Cancer Res; 2008 Oct; 68(19):7707-10. PubMed ID: 18829522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
